A German pharmaceutical manufacturer needed to replace its aging RO/EDI water purification system to meet updated EU GMP Annex 1 requirements and support a planned production line expansion. The existing 14-year-old system was unreliable, increasingly expensive to maintain, and no longer documented to current regulatory standards.
The client engaged RIEFILT under an Advisory + Equipment Sourcing mandate. RIEFILT performed a full technical audit, defined specifications, ran a competitive RFQ across 7 manufacturers and shortlisted 3 vendors with side-by-side TCO comparison — while remaining strictly manufacturer-independent.
The client secured the optimal equipment at approximately 18% below the lowest initial vendor quote thanks to RIEFILT's negotiation leverage and specification optimization. The new system passed EMA inspection on first attempt with zero observations and supports the new production line at 1,200 m³/day pharmaceutical-grade water output.
The water purification market is dominated by a small number of vendors who routinely tie clients into long-term service contracts. RIEFILT's manufacturer-independent advisory model ensures clients see the true competitive landscape, with transparent total-cost-of-ownership comparisons across all viable options.
This project was delivered on a fixed advisory fee — no hidden commissions, no equipment markups, no vendor kickbacks.
